Intended for healthcare professionals

Letters Patient organisations, NICE, and conflicts of interest

ABPI guidance on drug companies and patient organisations

BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l740 (Published 18 February 2019) Cite this as: BMJ 2019;364:l740
  1. Jill Pearcy, director
  1. Code Engagement, Association of the British Pharmaceutical Industry, London SW1E 6QT, UK
  1. jpearcy{at}abpi.org.uk

I read with interest your article on patient organisations and conflicts of interest and agree that, collectively, we should be striving to ensure high levels of transparency in our relationships across the health sector.1 The relationships that …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription